 anthony  noto  –  reporter,  new  york  business  journal  nov  16,  2018,  1:47pm  pst  pfizer  plans  raise  list  prices  41  prescription  drugs,  10  percent  portfolio,  january.  according  wall  street  journal,  citing  unnamed  source,  planned  increases  will  5  percent,  three  drugs’  list  prices  will  go  3  percent.  one  drug  prices  will  go  9  percent,  report  continued.  move  won’t  affect  90  percent  new  york  drug  company’s  portfolio,  including  newly  approved  medicines  sterile  injectables.  earlier  year,  pfizer  going  raise  list  prices  40  prescription  drugs  president  donald  trump  disparaged  company  twitter:  pfizer  &  others  ashamed  raised  drug  prices  reason.  merely  taking  advantage  poor  &  others  unable  defend  themselves,  time  giving  bargain  basement  prices  countries  europe  &  elsewhere.  we  will  respond!  phone  call  president  pfizer  chief  ian  read  eventually  took  place  pharma  giant  apparently  reversed  course  —  now.  pfizer  (nyse:  pfe)  expects  new  price  increases  take  effect  jan.  15.  meanwhile,  read  plans  resign  effective  jan.  1.  he  will  become  executive  chairman  deputy,  albert  bourla,  will  become  ceo.  pfizer,  employs  90,000  workers,  recently  announced  headcount  reduction  plan  part  company-wide  restructuring.  pharmaceutical  giant  offering  severance  packages  pay  base  salary  12  weeks,  plus  three  weeks  salary  every  year  work  (up  104  weeks).  employees  volunteer  buyout  will  also  get  take  vested  equity  them,  health  insurance  benefits  current  rates  three  years.  people  55  least  10  years  service  company  may  eligible  early  retirement  program.  oct.  16  nov.  2  opt  early  retirement  program.  people  lose  jobs  involuntarily  will  eligible  largely  benefits  program,  generous  typical  layoff  package,  company  said.  pfizer  market  capitalization  $250  billion. 